Gamificación estructural y su incidencia en la comprensión lectora en inglés
Plumilla Educativa · 2025
DOI: 10.30554/p.e.1.5009.2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Plumilla Educativa, 2025. Verfasst von Eliécer Pineda Ballesteros und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
This case report presents an academic exercise of implementing a strategy, based on structural gamification, to strengthen reading comprehension skills in English with ninth grade students, using ClassCraft®. A descriptive study was carried out with a mixed re- search approach, with a pre-experimental, pretest-posttest design. The strategy was developed through five didactic sequences sup- ported by vocabulary content, grammatical structures and exercises based on a world of adventures with fantastic characters. When the strategy was applied, there was an improvement of 57.14%, results that support the hypothesis that reading comprehension in English increases when implementing structural gamification in the classroom. The t-test showed that the difference between the test results was statistically significant, providing evidence that the tested proposal strengthens reading comprehension levels in English. In addition, the satisfaction survey reflected a high level of motivation.
Zitieren
APA
Ballesteros, E. P., Rivera, J. S. P., & Durán, L. M. Q. (2025). Gamificación estructural y su incidencia en la comprensión lectora en inglés. Plumilla Educativa. https://doi.org/10.30554/p.e.1.5009.2025
Vancouver
Ballesteros EP, Rivera JSP, Durán LMQ. Gamificación estructural y su incidencia en la comprensión lectora en inglés. Plumilla Educativa. 2025. doi:10.30554/p.e.1.5009.2025
BibTeX
@article{Ballesteros2025,
author = {Ballesteros, Eliécer Pineda and Rivera, Johan Salvador Pimiento and Durán, Lina Mercedes Quejada},
title = {Gamificación estructural y su incidencia en la comprensión lectora en inglés},
journal = {Plumilla Educativa},
year = {2025},
doi = {10.30554/p.e.1.5009.2025}
}
EUVIMED